Roll Call NJ

A4852: Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*

New Jersey General Assembly, June 30, 2026. 3RDG FINAL PASSAGE, roll call 174: 76 yes, 2 no, 1 abstained, 1 not voting.

Signed into law: P.L.2026, c.40 (July 8, 2026).

Prime sponsors: Andrea Katz, Marisa Sweeney, Vincent M. Kearney, Chris Tully, Joseph F. Vitale, Vin Gopal, Raj Mukherji.

Bill documents

How they voted

Yes (76)

No (2)

Abstained (1)

Not voting (1)

A4852 on the New Jersey Legislature website

Independent, unofficial recreation built from NJ Legislature data. This is not a government website, and no state time or resources were used.